Keywords: improving, fundamentals, amersham, int, international, imaging, agent

Improving Fundamentals At Amersham Int'l

Article | 22 April 1996

Amersham International's imaging agent Ceretec (99mTc/exametazine) has been found to have potential in the diagnosis of Alzheimer's disease, and ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Amersham

Bristol-Myers Squibb

Merck

Merck KGaA

Go to company listing

Related Drugs

Ceretec

Technetium Tc99m Exametazime Injection

Metastron

Strontium-89

Go to drug listing